← Back to Clinical Trials
Recruiting NCT06304285

A Study Assessing the Effects of Acupuncture in Parkinson's Disease Patients With Chronic Appendicitis

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Parkinson's Disease
Sponsor The First Affiliated Hospital of University of Science and Technology of China
Study Type INTERVENTIONAL
Phase N/A
Enrollment 84
Sex ALL
Min Age 40 Years
Max Age 70 Years
Start Date 2024-03-01
Completion 2026-12-31
Interventions
Acupuncture treatmentSham acupuncture treatment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The incidence of PD is high, and when the disease is serious to a certain extent, the effect of drugs to control symptoms decreases, resulting in a significant reduction in the quality of life of patients. Recent studies have found that these PD symptoms are closely related to the intestine. For several cases of PD syndrome patients complicated with chronic appendicitis, our research group conducted acupuncture on points related to constipation and chronic appendicitis, and found that constipation and related motor symptoms of patients could be significantly improved. Clinical studies have shown that acupuncture also has a certain therapeutic effect on non-motor symptoms of Parkinson's disease, such as anxiety and depression, decreased olfactory function, sleep disorders, constipation, early skeletal muscle pain, cognitive dysfunction, etc., which can delay the progression of the disease and improve the quality of life of patients. Starting from intestinal acupuncture, this project further clarified the role of acupuncture treatment in the comprehensive treatment of PD

Eligibility Criteria

Inclusion Criteria: * Patients presenting with bradykinesia, combined with resting tremor and/or myotonia. * Appendix CT suggested chronic appendicitis evaluated by two experienced experts. * All subjects and their guardians give informed consent to the content of this study and sign informed consent. * Normal coagulation function. * If the patient had taken oral anti-PD drugs, it had been stable for at least 2 weeks at enrollment. Exclusion Criteria: * Treatment with dopamine blockers or dopamine depleters in doses and time courses consistent with drug-induced parkinsonism. * Neuroimaging examination of presynaptic dopaminergic system function was normal. * Patients who had suffered severe brain trauma or underwent complex craniotomy within 5 years prior to enrollment. * Cognitive disorders that are not on the Parkinson's spectrum, such as Alzheimer's disease, frontotemporal dementia, and Niemann-Pick disease, have been diagnosed. * People diagnosed with severe neuropsychiatric disord

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}